FDA keeps pulling them along though. Another EUA... I thought leronlimab would be first with severe population. NP needs to seriously fact check his statements. He doesn't even realize that MESO also has a Phase 3 for s/c with mortality as endpoint.
For Immediate Release:
November 19, 2020
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug baricitinib, in combination with remdesivir, for the treatment of suspected or laboratory confirmed COVID-19 in hospitalized adults and pediatric patients two years of age or older requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).